Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT07087067
Eligibility Criteria:
Inclusion Criteria
Pregnant women were considered according to the subsequent criteria:
* Age ≥18 years.
* These criteria applied to both singleton and multifetal pregnant women.
* The gestational age was less than 12 weeks at the time of randomization, confirmed by a first-trimester ultrasound.
* Each participant must possess at least one of the major risk factors mentioned above.
* Being willing and able to give informed consent and follow trial processes. Exclusion Criteria
Exclusion criteria were strictly applied to reduce confounding and ensure participants' safety:
* Current or prior use of aspirin or other antiplatelet/anticoagulant therapy during the current pregnancy.
* Known hypersensitivity to aspirin.
* Peptic ulcer history, gastrointestinal bleeding, or coagulopathy.
* A platelet count of less than 100,000/μL or the presence of known bleeding disorders is a concern.
* Severe hepatic or renal dysfunction (CKD stage IV or above).
* Known major fetal anomaly or chromosomal abnormality.
* Engaging in a different clinical trial could potentially impact the results.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT07087067
Study Brief:
Protocol Section:
NCT07087067